Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
507 INR | -0.02% | +2.82% | -13.70% |
Apr. 23 | UPL Limited completed the acquisition of Cortevas Mancozeb Business from Corteva, Inc.. | CI |
Mar. 28 | UPL Limited(NSEI:UPL) dropped from Nifty 50 | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The company is in debt and has limited leeway for investment
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-13.70% | 4.56B | C+ | ||
+12.96% | 37.83B | C | ||
-.--% | 10.98B | - | B+ | |
-6.41% | 7.37B | A | ||
+3.97% | 6.64B | B- | ||
-3.08% | 6.09B | B+ | ||
-11.24% | 5.54B | - | C- | |
+29.81% | 5.13B | B- | ||
+11.23% | 4.15B | - | - | |
+7.51% | 3.89B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- UNITEDPHOS Stock
- Ratings UPL Limited